|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/36 | |
| A61K 39/395 | |||
| A61K 39/00 |
| (11) | Number of the document | 2222707 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08852770.0 |
| Date of filing the European patent application | 2008-11-21 | |
| (97) | Date of publication of the European application | 2010-09-01 |
| (45) | Date of publication and mention of the grant of the patent | 2016-01-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/084336 |
| Date | 2008-11-21 |
| (87) | Number | WO 2009/067660 |
| Date | 2009-05-28 |
| (30) | Number | Date | Country code |
| 989523 P | 2007-11-21 | US |
| (72) |
GRUBER, Andras, US
TUCKER, Erik, Ian, US
HANSON, Stephen, Raymond, US
GAILANI, David, US
|
| (73) |
Oregon Health & Science University,
3181 SW Sam Jackson Park Road, Portland, OR 97239,
US
Vanderbilt University, Office of Technology Transfer and Enterprise Development 305 Kirkland Hall, Nashville, TN 37240, US |
| (54) | ANTI-FACTOR XI MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF |
| ANTI-FACTOR XI MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF |